Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-28

Clinical Trial Update: The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating the safety and efficacy of fecal microbiota transplantation in individuals with major depressive disorder, including trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University of Calgary | Conditions: Depression, Treatment Resistant Depression | Phase 2, Phase 3 | Status: UNKNOWN